nodes	percent_of_prediction	percent_of_DWPC	metapath
Ardeparin—Skin necrosis—Cisplatin—bone cancer	0.0406	0.0406	CcSEcCtD
Ardeparin—Injection site haemorrhage—Epirubicin—bone cancer	0.0271	0.0271	CcSEcCtD
Ardeparin—Nodule—Methotrexate—bone cancer	0.0265	0.0265	CcSEcCtD
Ardeparin—Injection site haemorrhage—Doxorubicin—bone cancer	0.025	0.025	CcSEcCtD
Ardeparin—Diabetic—Methotrexate—bone cancer	0.0233	0.0233	CcSEcCtD
Ardeparin—Skin necrosis—Methotrexate—bone cancer	0.0223	0.0223	CcSEcCtD
Ardeparin—Skin necrosis—Epirubicin—bone cancer	0.0209	0.0209	CcSEcCtD
Ardeparin—Skin necrosis—Doxorubicin—bone cancer	0.0193	0.0193	CcSEcCtD
Ardeparin—Pain—Carboplatin—bone cancer	0.0148	0.0148	CcSEcCtD
Ardeparin—Hepatocellular injury—Cisplatin—bone cancer	0.0142	0.0142	CcSEcCtD
Ardeparin—Hyperkalaemia—Cisplatin—bone cancer	0.0139	0.0139	CcSEcCtD
Ardeparin—Osteoporosis—Methotrexate—bone cancer	0.0139	0.0139	CcSEcCtD
Ardeparin—Body temperature increased—Carboplatin—bone cancer	0.0136	0.0136	CcSEcCtD
Ardeparin—Skin exfoliation—Cisplatin—bone cancer	0.0135	0.0135	CcSEcCtD
Ardeparin—Local reaction—Epirubicin—bone cancer	0.0132	0.0132	CcSEcCtD
Ardeparin—Vesiculobullous rash—Epirubicin—bone cancer	0.013	0.013	CcSEcCtD
Ardeparin—Local reaction—Doxorubicin—bone cancer	0.0122	0.0122	CcSEcCtD
Ardeparin—Vesiculobullous rash—Doxorubicin—bone cancer	0.012	0.012	CcSEcCtD
Ardeparin—Thrombocytosis—Epirubicin—bone cancer	0.0117	0.0117	CcSEcCtD
Ardeparin—Liver disorder—Methotrexate—bone cancer	0.0114	0.0114	CcSEcCtD
Ardeparin—Paralysis—Methotrexate—bone cancer	0.0112	0.0112	CcSEcCtD
Ardeparin—Thrombocytosis—Doxorubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Cisplatin—bone cancer	0.0106	0.0106	CcSEcCtD
Ardeparin—Paralysis—Epirubicin—bone cancer	0.0105	0.0105	CcSEcCtD
Ardeparin—Thrombosis—Epirubicin—bone cancer	0.0103	0.0103	CcSEcCtD
Ardeparin—Hyperlipidaemia—Epirubicin—bone cancer	0.0101	0.0101	CcSEcCtD
Ardeparin—Dermatitis atopic—Epirubicin—bone cancer	0.00984	0.00984	CcSEcCtD
Ardeparin—Paralysis—Doxorubicin—bone cancer	0.0097	0.0097	CcSEcCtD
Ardeparin—Thrombosis—Doxorubicin—bone cancer	0.00952	0.00952	CcSEcCtD
Ardeparin—Hyperlipidaemia—Doxorubicin—bone cancer	0.00935	0.00935	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.00927	0.00927	CcSEcCtD
Ardeparin—Rash pustular—Epirubicin—bone cancer	0.00914	0.00914	CcSEcCtD
Ardeparin—Dermatitis atopic—Doxorubicin—bone cancer	0.00911	0.00911	CcSEcCtD
Ardeparin—Injection site pain—Epirubicin—bone cancer	0.00892	0.00892	CcSEcCtD
Ardeparin—Rash pustular—Doxorubicin—bone cancer	0.00845	0.00845	CcSEcCtD
Ardeparin—Injection site pain—Doxorubicin—bone cancer	0.00826	0.00826	CcSEcCtD
Ardeparin—Inflammation—Methotrexate—bone cancer	0.00803	0.00803	CcSEcCtD
Ardeparin—Vasculitis—Methotrexate—bone cancer	0.00798	0.00798	CcSEcCtD
Ardeparin—Myocardial infarction—Cisplatin—bone cancer	0.00778	0.00778	CcSEcCtD
Ardeparin—Inflammation—Epirubicin—bone cancer	0.00751	0.00751	CcSEcCtD
Ardeparin—Skin exfoliation—Methotrexate—bone cancer	0.00743	0.00743	CcSEcCtD
Ardeparin—Hepatocellular injury—Epirubicin—bone cancer	0.00729	0.00729	CcSEcCtD
Ardeparin—Hyperkalaemia—Epirubicin—bone cancer	0.00716	0.00716	CcSEcCtD
Ardeparin—Ecchymosis—Methotrexate—bone cancer	0.00704	0.00704	CcSEcCtD
Ardeparin—Skin exfoliation—Epirubicin—bone cancer	0.00696	0.00696	CcSEcCtD
Ardeparin—Inflammation—Doxorubicin—bone cancer	0.00695	0.00695	CcSEcCtD
Ardeparin—Pulmonary oedema—Methotrexate—bone cancer	0.00693	0.00693	CcSEcCtD
Ardeparin—Hepatocellular injury—Doxorubicin—bone cancer	0.00674	0.00674	CcSEcCtD
Ardeparin—Hyperkalaemia—Doxorubicin—bone cancer	0.00662	0.00662	CcSEcCtD
Ardeparin—Ecchymosis—Epirubicin—bone cancer	0.00659	0.00659	CcSEcCtD
Ardeparin—Diabetes mellitus—Methotrexate—bone cancer	0.0065	0.0065	CcSEcCtD
Ardeparin—Pulmonary oedema—Epirubicin—bone cancer	0.00649	0.00649	CcSEcCtD
Ardeparin—Skin exfoliation—Doxorubicin—bone cancer	0.00644	0.00644	CcSEcCtD
Ardeparin—Alopecia—Cisplatin—bone cancer	0.0063	0.0063	CcSEcCtD
Ardeparin—Erythema—Cisplatin—bone cancer	0.0062	0.0062	CcSEcCtD
Ardeparin—Ecchymosis—Doxorubicin—bone cancer	0.0061	0.0061	CcSEcCtD
Ardeparin—Diabetes mellitus—Epirubicin—bone cancer	0.00608	0.00608	CcSEcCtD
Ardeparin—Pulmonary oedema—Doxorubicin—bone cancer	0.006	0.006	CcSEcCtD
Ardeparin—Vascular purpura—Epirubicin—bone cancer	0.00591	0.00591	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Methotrexate—bone cancer	0.00584	0.00584	CcSEcCtD
Ardeparin—Anaemia—Cisplatin—bone cancer	0.00573	0.00573	CcSEcCtD
Ardeparin—Diabetes mellitus—Doxorubicin—bone cancer	0.00563	0.00563	CcSEcCtD
Ardeparin—Malaise—Cisplatin—bone cancer	0.00559	0.00559	CcSEcCtD
Ardeparin—Dermatitis bullous—Epirubicin—bone cancer	0.00553	0.00553	CcSEcCtD
Ardeparin—Purpura—Epirubicin—bone cancer	0.00549	0.00549	CcSEcCtD
Ardeparin—Vascular purpura—Doxorubicin—bone cancer	0.00547	0.00547	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Epirubicin—bone cancer	0.00546	0.00546	CcSEcCtD
Ardeparin—Cardiac failure—Epirubicin—bone cancer	0.00542	0.00542	CcSEcCtD
Ardeparin—Dermatitis bullous—Doxorubicin—bone cancer	0.00512	0.00512	CcSEcCtD
Ardeparin—Purpura—Doxorubicin—bone cancer	0.00508	0.00508	CcSEcCtD
Ardeparin—Oedema—Cisplatin—bone cancer	0.00506	0.00506	CcSEcCtD
Ardeparin—Anaphylactic shock—Cisplatin—bone cancer	0.00506	0.00506	CcSEcCtD
Ardeparin—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00506	0.00506	CcSEcCtD
Ardeparin—Cardiac failure—Doxorubicin—bone cancer	0.00501	0.00501	CcSEcCtD
Ardeparin—Thrombocytopenia—Cisplatin—bone cancer	0.00496	0.00496	CcSEcCtD
Ardeparin—Eosinophilia—Methotrexate—bone cancer	0.00484	0.00484	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00476	0.00476	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00466	0.00466	CcSEcCtD
Ardeparin—Eosinophilia—Epirubicin—bone cancer	0.00453	0.00453	CcSEcCtD
Ardeparin—Dyspnoea—Cisplatin—bone cancer	0.00451	0.00451	CcSEcCtD
Ardeparin—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00441	0.00441	CcSEcCtD
Ardeparin—Pneumonia—Methotrexate—bone cancer	0.00438	0.00438	CcSEcCtD
Ardeparin—Pain—Cisplatin—bone cancer	0.00433	0.00433	CcSEcCtD
Ardeparin—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00432	0.00432	CcSEcCtD
Ardeparin—Eosinophilia—Doxorubicin—bone cancer	0.00419	0.00419	CcSEcCtD
Ardeparin—Feeling abnormal—Cisplatin—bone cancer	0.00417	0.00417	CcSEcCtD
Ardeparin—Haematuria—Methotrexate—bone cancer	0.00415	0.00415	CcSEcCtD
Ardeparin—Pneumonia—Epirubicin—bone cancer	0.0041	0.0041	CcSEcCtD
Ardeparin—Body temperature increased—Cisplatin—bone cancer	0.004	0.004	CcSEcCtD
Ardeparin—Haemoglobin—Methotrexate—bone cancer	0.00393	0.00393	CcSEcCtD
Ardeparin—Haemorrhage—Methotrexate—bone cancer	0.00391	0.00391	CcSEcCtD
Ardeparin—Haematuria—Epirubicin—bone cancer	0.00389	0.00389	CcSEcCtD
Ardeparin—Pneumonia—Doxorubicin—bone cancer	0.00379	0.00379	CcSEcCtD
Ardeparin—Hypersensitivity—Cisplatin—bone cancer	0.00373	0.00373	CcSEcCtD
Ardeparin—Haemoglobin—Epirubicin—bone cancer	0.00368	0.00368	CcSEcCtD
Ardeparin—Haemorrhage—Epirubicin—bone cancer	0.00366	0.00366	CcSEcCtD
Ardeparin—Oedema peripheral—Epirubicin—bone cancer	0.0036	0.0036	CcSEcCtD
Ardeparin—Haematuria—Doxorubicin—bone cancer	0.0036	0.0036	CcSEcCtD
Ardeparin—Diarrhoea—Cisplatin—bone cancer	0.00346	0.00346	CcSEcCtD
Ardeparin—Alopecia—Methotrexate—bone cancer	0.00345	0.00345	CcSEcCtD
Ardeparin—Erythema—Methotrexate—bone cancer	0.0034	0.0034	CcSEcCtD
Ardeparin—Haemoglobin—Doxorubicin—bone cancer	0.0034	0.0034	CcSEcCtD
Ardeparin—Haemorrhage—Doxorubicin—bone cancer	0.00339	0.00339	CcSEcCtD
Ardeparin—Oedema peripheral—Doxorubicin—bone cancer	0.00334	0.00334	CcSEcCtD
Ardeparin—Alopecia—Epirubicin—bone cancer	0.00323	0.00323	CcSEcCtD
Ardeparin—Erythema—Epirubicin—bone cancer	0.00319	0.00319	CcSEcCtD
Ardeparin—Anaemia—Methotrexate—bone cancer	0.00315	0.00315	CcSEcCtD
Ardeparin—Malaise—Methotrexate—bone cancer	0.00307	0.00307	CcSEcCtD
Ardeparin—Nausea—Cisplatin—bone cancer	0.00301	0.00301	CcSEcCtD
Ardeparin—Alopecia—Doxorubicin—bone cancer	0.00299	0.00299	CcSEcCtD
Ardeparin—Erythema—Doxorubicin—bone cancer	0.00295	0.00295	CcSEcCtD
Ardeparin—Anaemia—Epirubicin—bone cancer	0.00294	0.00294	CcSEcCtD
Ardeparin—Malaise—Epirubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Ardeparin—Confusional state—Methotrexate—bone cancer	0.0028	0.0028	CcSEcCtD
Ardeparin—Anaphylactic shock—Methotrexate—bone cancer	0.00278	0.00278	CcSEcCtD
Ardeparin—Anaemia—Doxorubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Ardeparin—Thrombocytopenia—Methotrexate—bone cancer	0.00272	0.00272	CcSEcCtD
Ardeparin—Malaise—Doxorubicin—bone cancer	0.00266	0.00266	CcSEcCtD
Ardeparin—Confusional state—Epirubicin—bone cancer	0.00262	0.00262	CcSEcCtD
Ardeparin—Oedema—Epirubicin—bone cancer	0.0026	0.0026	CcSEcCtD
Ardeparin—Anaphylactic shock—Epirubicin—bone cancer	0.0026	0.0026	CcSEcCtD
Ardeparin—Shock—Epirubicin—bone cancer	0.00256	0.00256	CcSEcCtD
Ardeparin—Thrombocytopenia—Epirubicin—bone cancer	0.00255	0.00255	CcSEcCtD
Ardeparin—Dyspnoea—Methotrexate—bone cancer	0.00248	0.00248	CcSEcCtD
Ardeparin—Confusional state—Doxorubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Ardeparin—Anaphylactic shock—Doxorubicin—bone cancer	0.00241	0.00241	CcSEcCtD
Ardeparin—Oedema—Doxorubicin—bone cancer	0.00241	0.00241	CcSEcCtD
Ardeparin—Pain—Methotrexate—bone cancer	0.00238	0.00238	CcSEcCtD
Ardeparin—Shock—Doxorubicin—bone cancer	0.00237	0.00237	CcSEcCtD
Ardeparin—Thrombocytopenia—Doxorubicin—bone cancer	0.00235	0.00235	CcSEcCtD
Ardeparin—Dyspnoea—Epirubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Ardeparin—Feeling abnormal—Methotrexate—bone cancer	0.00229	0.00229	CcSEcCtD
Ardeparin—Pain—Epirubicin—bone cancer	0.00222	0.00222	CcSEcCtD
Ardeparin—Urticaria—Methotrexate—bone cancer	0.00221	0.00221	CcSEcCtD
Ardeparin—Body temperature increased—Methotrexate—bone cancer	0.0022	0.0022	CcSEcCtD
Ardeparin—Dyspnoea—Doxorubicin—bone cancer	0.00214	0.00214	CcSEcCtD
Ardeparin—Feeling abnormal—Epirubicin—bone cancer	0.00214	0.00214	CcSEcCtD
Ardeparin—Urticaria—Epirubicin—bone cancer	0.00207	0.00207	CcSEcCtD
Ardeparin—Pain—Doxorubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Ardeparin—Body temperature increased—Epirubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Ardeparin—Hypersensitivity—Methotrexate—bone cancer	0.00205	0.00205	CcSEcCtD
Ardeparin—Feeling abnormal—Doxorubicin—bone cancer	0.00198	0.00198	CcSEcCtD
Ardeparin—Pruritus—Methotrexate—bone cancer	0.00197	0.00197	CcSEcCtD
Ardeparin—Hypersensitivity—Epirubicin—bone cancer	0.00192	0.00192	CcSEcCtD
Ardeparin—Urticaria—Doxorubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Ardeparin—Body temperature increased—Doxorubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Ardeparin—Diarrhoea—Methotrexate—bone cancer	0.0019	0.0019	CcSEcCtD
Ardeparin—Pruritus—Epirubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Ardeparin—Diarrhoea—Epirubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Ardeparin—Hypersensitivity—Doxorubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Ardeparin—Headache—Methotrexate—bone cancer	0.00174	0.00174	CcSEcCtD
Ardeparin—Pruritus—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Ardeparin—Nausea—Methotrexate—bone cancer	0.00165	0.00165	CcSEcCtD
Ardeparin—Diarrhoea—Doxorubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Ardeparin—Headache—Epirubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Ardeparin—Nausea—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Ardeparin—Headache—Doxorubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Ardeparin—Nausea—Doxorubicin—bone cancer	0.00143	0.00143	CcSEcCtD
